Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

GW Pharmaceuticals Plc GWPRF


Primary Symbol: GWPHV



NDAQ:GWPHV - Post by User

GW Pharmaceuticals Plc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(12)
•••
Post by Bullknit101on Jan 11, 2021 8:25am
235 Views
Post# 32265497

GW Pharma Earnings

GW Pharma Earnings As InMed Pharma investor, I'm watching both closely since once GW ramps up clinical trials with rare cannabinoids, they are likely to use InMed manufacturing technology. https://www.newcannabisventures.com/gw-pharma-pre-announces-q4-revenue-of-148-million-ahead-of-expectations/
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities